DD295846A5 - Verfahren zur herstellung weiterer neuer alkanophenone - Google Patents

Verfahren zur herstellung weiterer neuer alkanophenone Download PDF

Info

Publication number
DD295846A5
DD295846A5 DD90344067A DD34406790A DD295846A5 DD 295846 A5 DD295846 A5 DD 295846A5 DD 90344067 A DD90344067 A DD 90344067A DD 34406790 A DD34406790 A DD 34406790A DD 295846 A5 DD295846 A5 DD 295846A5
Authority
DD
German Democratic Republic
Prior art keywords
hydroxy
acetyl
oxo
benzopyran
dien
Prior art date
Application number
DD90344067A
Other languages
German (de)
English (en)
Inventor
Andreas Von Sprecher
Andreas Beck
Original Assignee
����`��@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����`��@���k�� filed Critical ����`��@���k��
Publication of DD295846A5 publication Critical patent/DD295846A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
DD90344067A 1989-09-19 1990-09-17 Verfahren zur herstellung weiterer neuer alkanophenone DD295846A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH340189 1989-09-19

Publications (1)

Publication Number Publication Date
DD295846A5 true DD295846A5 (de) 1991-11-14

Family

ID=4255188

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90344067A DD295846A5 (de) 1989-09-19 1990-09-17 Verfahren zur herstellung weiterer neuer alkanophenone

Country Status (16)

Country Link
US (1) US5145868A (fr)
EP (1) EP0419410A3 (fr)
JP (1) JPH03112987A (fr)
KR (1) KR910006269A (fr)
AU (1) AU630231B2 (fr)
CA (1) CA2025470A1 (fr)
DD (1) DD295846A5 (fr)
FI (1) FI904570A7 (fr)
HU (1) HU207067B (fr)
IE (1) IE903375A1 (fr)
IL (1) IL95678A0 (fr)
MX (1) MX22430A (fr)
NO (1) NO904069L (fr)
NZ (1) NZ235335A (fr)
PT (1) PT95336A (fr)
ZA (1) ZA907422B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2415210C (fr) 2000-07-04 2011-12-06 Shohei Fukuda Compose de benzoxazole, son procede de production, et desherbant
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
NZ532096A (en) 2001-09-28 2006-10-27 Mcneil Ppc Inc Dosage forms having an inner core and outer shell with different shapes
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
WO2004058786A1 (fr) * 2002-12-31 2004-07-15 Council Of Scientific And Industrial Research Processus de synthese de deoxy-d-glucose
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3275295D1 (en) * 1981-11-12 1987-03-05 Fisons Plc Anti-srs-a carboxylic acid derivatives, processes for their production, and pharmaceutical formulation containing them
US4609744A (en) * 1983-04-21 1986-09-02 Merck Frosst Canada Inc. 4-oxo-benzopyran carboxylic acids
DE3469169D1 (en) * 1983-04-21 1988-03-10 Merck Frosst Canada Inc Leukotriene antagonists, their production and use and compositions containing them
GB8320943D0 (en) * 1983-08-03 1983-09-07 Lilly Industries Ltd Organic compounds
EP0147217A3 (fr) * 1983-12-27 1986-08-13 Merck Frosst Canada Inc. Antagonistes de leucotriènes
US4761425A (en) * 1983-12-27 1988-08-02 Merck Frosst Canada, Inc. Leukotriene antagonists
US4649215A (en) * 1984-06-28 1987-03-10 Ciba-Geigy Corporation Aliphatic thioethers
CA1309557C (fr) * 1985-06-18 1992-10-27 Robert N. Young Antagonistes de leucotrienes
US4808572A (en) * 1985-12-06 1989-02-28 Ciba-Geigy Corporation α-Hydroxy thioethers
US4785004A (en) * 1985-12-23 1988-11-15 Ciba-Geigy Corporation Aromatic thioethers
JPH0753725B2 (ja) * 1987-10-08 1995-06-07 富山化学工業株式会社 4h―1―ベンゾピラン―4―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤
IL89713A0 (en) * 1988-03-29 1989-09-28 Ciba Geigy Ag Novel alkanophenones

Also Published As

Publication number Publication date
JPH03112987A (ja) 1991-05-14
EP0419410A3 (en) 1991-08-14
PT95336A (pt) 1991-05-22
HUT54677A (en) 1991-03-28
NZ235335A (en) 1992-12-23
NO904069L (no) 1991-03-20
MX22430A (es) 1993-12-01
IL95678A0 (en) 1991-06-30
NO904069D0 (no) 1990-09-18
KR910006269A (ko) 1991-04-29
HU207067B (en) 1993-03-01
FI904570A0 (fi) 1990-09-17
AU630231B2 (en) 1992-10-22
FI904570A7 (fi) 1991-03-20
IE903375A1 (en) 1991-04-10
ZA907422B (en) 1991-05-29
AU6260690A (en) 1991-03-28
US5145868A (en) 1992-09-08
CA2025470A1 (fr) 1991-03-20
EP0419410A2 (fr) 1991-03-27

Similar Documents

Publication Publication Date Title
EP0763037B1 (fr) DERIVES DE PYRROLE [a]-ANNELES ET LEUR UTILISATION DANS LE DOMAINE PHARMACEUTIQUE
EP0228045B1 (fr) Thioéthers aromatiques
DE69631688T2 (de) Indanverbindungen mit relaxierender Wirkung auf die glatten Muskeln und/oder mit Mastzellen stabilisierender und/oder entzündungshemmender Wirkung
DE2228012B2 (de) -Aminophenylacetamido] -penicülansäure und Verfahren zu seiner Herstellung
EP0029247B1 (fr) Acides alcényl-thiényl-alcane carboxyliques et leurs dérivés, procédé pour leur préparation et médicaments les contenant
EP0335315B1 (fr) Alcanophénones
DE69201302T2 (de) Therapeutische zusammenstellungen auf der basis von 1,2-dithiole-3-thionderivaten.
EP0170048B1 (fr) Thioéthers aliphatiques
DD295846A5 (de) Verfahren zur herstellung weiterer neuer alkanophenone
EP0225602B1 (fr) Alpha-hydroxythioéthers
DE2745598A1 (de) Arylschwefelverbindungen, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel
DE3107743A1 (de) Neue klasse von acylderivaten des carnitins, verfahren zu deren herstellung sowie ihre therapeutische verwendung
EP0455596B1 (fr) Indoles substitués
CH616935A5 (en) Process for the preparation of chromone derivatives
DE69107274T2 (de) Phenoxyessigsäure-Derivate, Verfahren zu ihrer Herstellung, und pharmazeutische Zusammensetzungen die sie enthalten.
DE2825855C3 (de) 15-substituierte-ι-Pentanorprostaglandin-derivate
DD261149A5 (de) Verfahren zur herstellung neuartiger unsymmetrischer thioehter
DE2524955C3 (de) Neue Thienyl-Prostaglandine und Verfahren zu ihrer Herstellung
DD243697A5 (de) Aliphatische thioether
EP0419411A2 (fr) Alkanophénones additionnels
DD234008A5 (de) Flavene and thioflavene derivates, processes for their manufacture, pharmaceutical preparationsthat contain such compounds, and the use of the latter
EP0301402B1 (fr) Antagonistes de leukotriènes procédé pour leur préparation et leur emploi dans le traitement de maladies
DE69016378T2 (de) Substituierte Benzothiazolinone, ihre Herstellung und sie enthaltende pharmazeutische Zusammenstellungen.
DD299173A5 (de) Leukotrien-antagonisten
DE69105489T2 (de) S-(2-thenoyl)-thiolactonsäure mit pharmazeutischer wirkung.

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee